NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
NIDCD will reissue a grant for multidisciplinary clinical research centers focused on sensory/communication disorders, offering optional clinical trials and aiming for innovative solutions.
Funder: National Institutes of Health
Due Dates: June 2, 2026 | October 2, 2026 | October 3, 2026
Funding Amounts: Up to $1,500,000/year direct costs (new applications); renewals may request up to 10% above the last year or $2,000,000/year (whichever is less); max project period 5 years.
Summary: Supports multidisciplinary clinical research centers advancing the diagnosis, prevention, and treatment of human sensory and communication disorders in areas such as hearing, balance, smell, taste, voice, speech, or language.
Key Information: Clinical trials are optional but must be low-risk; strong integration and synergy among 3-4 projects around a unifying theme required.
Description
The National Institute on Deafness and Other Communication Disorders (NIDCD) Clinical Research Center Grant (P50) supports the establishment of multidisciplinary centers focused on advancing clinical research in the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. Research must be centered on individuals with sensory and/or communication disorders, or on data/tissues derived from such individuals. Examples include studies of hearing, balance, smell, taste, voice, speech, or language.
Centers must propose 3–4 synergistic research projects integrated around a unifying theme, supported by an administrative core (required) and up to two optional scientific cores. Projects may involve low-risk clinical trials (optional), as well as non-human or at-risk human research if scientifically justified. The program is designed to foster innovative, integrated approaches that have impact beyond the sum of individual projects.
